AI 创业公司融资日历

1819 家公司 1840 轮融资 306 家已接到招聘板 全部在招职位 →

💡 刚融资 = 正在扩招。 创业公司拿到钱第一件事就是扩团队——先到先得。看到心仪的公司刚融资,点"→ 在招岗位",趁招聘高峰投。

轮次 全部 Series ASeedSeries BSeries CSeries DPre-SeedGrowthSeries EDebtSeries FSeries G+RoundPrivate Equity
领域 全部 FinTechAI InfrastructureEnterprise SaaSDeveloper ToolsHealthcareHardware & RoboticsConsumerCybersecurityMarketing & AdTechData & AnalyticsPropTech & ConstructionInfrastructureClimate TechHR & Workforce
筛选 ✅ 只看正在招人的 ≥ $50M 2026 年 ✕ 清除全部

当前显示 12 轮 · 合计 $805M · 其中 0 家正在招人

2026 年 2月1 轮

Third Arc Bio Series A $52M Biotech 累计 $217M
Third Arc Bio is an immunology and inflammation-focused biotechnology company developing targeted immune therapeutics across oncology and inflammatory…
未接到招聘板 待核实

2026 年 1月3 轮

Breakthru Medicine Series A $60M Biotech
Breakthru Medicine is a biotech company developing novel oncology therapies, with a focus on first-in-class radioconjugate treatment approaches for ca…
未接到招聘板 待核实
Converge Bio Series A $25M Biotech 累计 $30M
Converge Bio develops generative AI platform trained on molecular data to help pharma and biotech companies discover and develop more effective drugs …
未接到招聘板 待核实
Prudentia Sciences Series A $20M Biotech 累计 $27M
Prudentia Sciences develops AI software for life-sciences diligence, asset valuation, and investment decision support across biopharma programs.
未接到招聘板 待核实

2025 年 12月2 轮

Medra Series A $52M Biotech 累计 $63M
Medra develops autonomous AI-powered robotic scientists that run and refine laboratory experiments end-to-end, interfacing with standard lab tools to …
未接到招聘板 待核实
Morphocell Technologies Series A $10M Biotech 累计 $50M
Regenerative medicine company developing stem cell-derived tissue and organ replacement therapies for liver disease using iPSC-derived platform techno…
未接到招聘板 待核实

2025 年 10月2 轮

Lila Sciences Series A $350M Biotech 累计 $550M
A platform using artificial intelligence to support research in life sciences, chemical sciences, and materials sciences through autonomous AI labs bu…
未接到招聘板 待核实
NILO Therapeutics Series A $101M Biotech
Nilo Therapeutics is a New York-based biotech developing a new class of medicines that harness brain-body neural circuits to restore immune homeostasi…
未接到招聘板 待核实

2025 年 9月1 轮

Until Series A $58M Biotech 累计 $106M
Until Labs develops reversible cryopreservation technology to pause biological time, starting with organ-scale preservation to extend the viability of…
未接到招聘板 待核实

2025 年 5月1 轮

Biostate AI Series A $12M Biotech 累计 $20M
A scalable biological data collection service providing multi-omics data for research.
未接到招聘板 待核实

2025 年 2月1 轮

Latent Series A $40M Biotech 累计 $50M
AI foundation models platform focused on making biology programmable and accelerating protein design.
未接到招聘板 待核实

2021 年 10月1 轮

Kingdom Supercultures Series A $25M Biotech 累计 $29M
Kingdom Supercultures engineers microbes to create functional ingredients for food and beverage brands.
未接到招聘板 待核实